Rombotis Spiro George
Insider CIK 1357396 · CYCC President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYCC Cyclacel Pharmaceuticals, | P Buy deriv | 2023-12-21 | 2023-12-26 | 6,070 | — | $0 | 6,070 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | P Buy | 2023-12-21 | 2023-12-26 | 6,070 | $3.32 | $20.2K | 68,658 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2023-06-30 | 2023-07-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2023-01-31 | 2023-02-02 | 57,600 | — | $0 | 62,588 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2021-12-13 | 2021-12-15 | 190,000 | — | $0 | 190,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2021-12-13 | 2021-12-16 | 190,000 | — | $0 | 190,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | P Buy | 2021-11-18 | 2021-11-22 | 4,000 | $4.50 | $18.0K | 4,988 | SEC↗ |
| CYCC | A Award deriv | 2020-12-11 | 2020-12-15 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-12-05 | 2019-12-09 | 15,625 | — | $0 | 15,625 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-12-05 | 2019-12-09 | 15,625 | — | $0 | 15,625 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-01-04 | 2019-01-07 | 508,198 | — | $0 | 508,198 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-01-03 | 2019-01-07 | 15,625 | — | $0 | 15,625 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-01-03 | 2019-01-07 | 14,375 | — | $0 | 14,375 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2015-12-07 | 2015-12-09 | 437,569 | — | $0 | 437,569 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2015-02-18 | 2015-02-20 | 81,742 | — | $0 | 81,742 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2013-12-09 | 2013-12-10 | 105,000 | — | $0 | 105,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | P Buy | 2013-05-21 | 2013-05-22 | 100,000 | $3.00 | $300.0K | 268,292 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | P Buy | 2013-05-21 | 2013-05-24 | 100,000 | $3.00 | $300.0K | 241,416 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2013-01-25 | 2013-01-29 | 10,791 | — | $0 | 168,292 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2013-01-25 | 2013-01-29 | 20,000 | — | $0 | 157,501 | SEC↗ |